Delivery Order SPE2DB22D1106-SPE2DB25FFFV4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pregnyl 10,000 unit vials, with a ceiling value of $1,813.50. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,753.52 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- This delivery order, valued at $7,254.00, was awarded to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pregnyl 10,000 unit vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a child contract under a larger federal procurement vehicle. The award was made without a set-aside designation, indicating open competition. The place of performance is located in Conshohocken, Pennsylvania, the headquarters of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.70 firm-fixed-price contract is for the supply of PREGNYL 10,000 UNIT VIALS, a medical product, with a completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This delivery order, valued at $2,418.00, awards Amerisourcebergen Drug Corp the supply of Pregnyl 10,000 unit vials for the Defense Logistics Agency. The contract is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement standards through open...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 10,000 unit vials of the pharmaceutical product Pregnyl. The contract has a ceiling value of $1,255.56 and a performance period through March 27, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp,...
- This delivery order, valued at $2,418.00, was awarded on July 30, 2025, to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. The contract, which is not set-aside and carries a firm fixed price structure, will be performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The Defense Logistics Agency (DLA), under the Department of Defense, issued this award as part of its ongoing pharmaceutical procurement...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,388.96 firm fixed-price contract is for the delivery of 4,565,131,503 vials of Pregnyl 10,000 unit medication. The contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFV4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pregnyl 10,000 Unit Vials, a human chorionic gonadotropin pharmaceutical product. This firm fixed-price delivery order, valued at $1,813.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was competitively made with no set-aside designation, and the contractor will perform from its facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role within the DLA's global pharmaceutical support network, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates the company's capability to fulfill specialized pharmaceutical needs through the flexible delivery order mechanism under its prime IDC vehicle with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/28/25 |